Dennis M. Gross, MS, PhD, received his BA and MS in biology from the California State University and his PhD in cell biology from the University of California, Los Angeles. He did his postdoctoral training in pharmacology at Tulane University School of Medicine before joining the Merck Research Labs where he worked for 29 years. During his tenure at Merck, he served as adjunct faculty in the Jefferson Graduate School of Biomedical Sciences and associate professor of pharmacology in the Department of Pharmacology and Experimental Therapeutics at Thomas Jefferson University. He also served as adjunct professor of global logistics in the School of Business and Industry of Florida A&M University. After retiring from Merck, he moved full-time to Thomas Jefferson University and served for nine years as the associate dean for the Jefferson Graduate School of Biomedical Sciences and associate professor of pharmacology in the Department of Pharmacology and Experimental Therapeutics at Thomas Jefferson University. Dr. Gross is currently the CEO and treasurer of the Pennsylvania Drug Discovery Institute. He continues as adjunct faculty in the Jefferson College of Biomedical Sciences and the Sydney Kimmel Medical College of Thomas Jefferson University. He is also professor of experimental therapeutics and medicinal chemistry in the Baruch S. Blumberg Institute and adjunct professor of basic sciences at Geisinger Commonwealth School of Medicine. He has published more than 120 scientific publications and is a member of the American Association for Pharmaceutical Scientists, American Chemical Society’s Medicinal Chemistry Division, International Society for Pharmaceutical Engineering, Sigma Xi and the Sino-American Pharmaceutical Professionals Association. He is also the national co-chair of the Biotechnology Entrepreneurship Boot Camp held in conjunction with the yearly International BIO meeting.
His activities involve business development, technology transfer and entrepreneurship in the life sciences, operations management, strategic planning and laboratory design, sustainability and business continuity planning and extensive experience in advising about alternative career paths for life science students.
- Silverman, I.M., Dawicki-Mckenna, J.M., Frederick, D.W., Bialas, C., Remberg, J.R., Yohn, N.L. Sekulic, N., Reitz, A.B. and Gross, D.M. Evaluating the Success of the Small Business Innovation Research (SBIR) Program: Impact on Biotechnology Companies in Pennsylvania. Technology Transfer and Entrepreneurship 2(2):4-13 (2015)
- Gross, D.M. Commentary: If you build it will they come? Real estate, the Lab and the Biopharma Outlook. Technology Transfer and Entrepreneurship 3(1):7-10 (2016)
- Gross, D.M. Preface to Volume 3. Technology Transfer and Entrepreneurship 3(1): 4 (2016)
- Bialas, C., Higbee-Dempsey, E., Chen, C.Y., Ward, C., Marcos-Contreras, O.A., Mulreany, D. Reitz, A.B. and Gross, D.M. Analyzing the FDA Priority Review Voucher Program’s Stimulation of Research and Public Health Impact. Technology Transfer and Entrepreneurship 3(2): 131-141 (2016)
BA in Biology - California State University (1969)
MS in Biology - California State University (1970)
PhD in Cell Biology - University of California, Los Angeles (1974)
Postdoctoral Fellowship - Tulane University School of Medicine (1974 - 1977)